(b)(4).Evaluation is in progress, conclusion not yet available.The actual device has been returned.The sample has been decontaminated but not yet evaluated by the supplier.At this time the complaint cannot be confirmed.There was no indication as to where the hemoconcentrator was inserted in the cpb circuit.The device history record (edhr) was reviewed for any anomalies, there were no issues noted.Additionally our supplier has provided initial evaluation of their device history record and release documentation and there were no indications of production related anomalies, or nonconforming inspections.All available information has been place on file in quality management for appropriate tracking, trending and follow-up.The case level gtin for this pack is (b)(4).The production identifiers are (b)(4).
|
The sample was received by the supplier and upon receipt it was visually inspected, there was no obvious anomaly such as a fiber break noted.The sample was then rinsed, dried, and again subjected to another visual inspection, there were no anomalies such a fiber break or clog in the fiber noted.The sample was then built into a circuit with tubing, where bovine blood (ht25%@37c) was circulated through the sample.The blood was confirmed to flow all the way through the sample with no issues.The blood was circulated at a flow rate of 500ml/min and tmp400mmhg, although a pressure drop was noted it was determined to be within specification.No clogging was observed.Based on the evaluation of the supplier, the actual sample was verified to be the normal product, presenting no clogging in the fiber.Therefore, the customer's complaint was not confirmed.All available information has been placed on file in quality management for appropriate tracking, trending and follow-up.
|